Clinical Trial Update: Safety Study to Assess Atomoxetine With MA Abusers and Healthy Controls [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating atomoxetine in methamphetamine abusers and healthy controls has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Continuous Methamphetamine Dependence
• Methamphetamine Dependence in Remission

Drugs mentioned

• Atomoxetine (Atomoxetine)
• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Continuous Methamphetamine Dependence, Methamphetamine Dependence in Remission | Phase 1 | Status: COMPLETED